Angiogenic balance in pregnancy and subsequent breast cancer risk and survival: A population study

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 7, 2009, Pages 2074-2078

  Vatten, Lars J ^a   Romundstad, Pål R ^a   Jenum, Pål A ^b   Eskild, Anne ^c,d,e  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b VESTRE VIKEN HOSPITAL TRUST   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^e AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ENDOGLIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FMS RELATED TYROSINE KINASE 1; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; ONCOGENE; POPULATION RISK; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; SURVIVAL;

ADULT; ANTIGENS, CD; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; LOGISTIC MODELS; NEOVASCULARIZATION, PHYSIOLOGIC; NORWAY; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PREGNANCY PROTEINS; RECEPTORS, CELL SURFACE; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 67650395591     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0207     Document Type: Article

References (17)

1. Trichopoulos D, Hsieh CC, McMahon B, et al. Age at any birth and breast cancer risk. Int J Cancer 1983;31:701-4.
2. Kelsey JL. Breast cancer epidemiology: summary and future directions. Epidemiol Rev 1993;15:256-63.
3. Melbye M, Wohlfahrt J, Olsen JH, et al. Induced abortion and the risk of breast cancer. N Engl J Med 1997;336:81-5.
4. Vatten LJ, Romundstad PR, Trichopoulos D, Skjærven R. Pregnancy related protection against breast cancer depends on length of gestation. Br J Cancer 2002;87:288-90.
5. Polednak AP, Janerich DT. Characteristics of first pregnancy in relation to early breast cancer. A case-control study. J Reprod Med 1983;28:314-8.
6. Cohn BA, Cirillo PN, Christianson RE, van den Berg BJ, Siiteri PK. Placental characteristics and reduced risk of maternal breast cancer. J Natl Cancer Inst 2001;93:1133-40.
7. Vatten LJ, Romundstad PR, Trichopoulos D, Skjærven R. Preeclampsia in pregnancy and subsequent risk for breast cancer. Br J Cancer 2002;87:971-3.
8. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase (sFlt1) may contribute to endothelial dysfunction, hypertension and proteinuria in preeclampsia. J Clin Invest 2003;111:649-58.
9. Levine R, Lan C, Quian C, et al. Soluble endoglin and other antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992-1005.
10. Aagaard-Tillery KM, Stoddard GJ, Holmgren C, et al. Preeclampsia and subsequent risk of cancer in Utah. Am J Obstet Gynecol 2006;195:691-9.
11. Hoar FJ, Lip GY, Belgore F, Stonelake PS. Circulating levels of VEGFA, VEGF-D and soluble VEGF-A receptor (sFlt-1) in human breast cancer. Int J Biol Markers 2004;19:229-35.
12. Parr C, Watkins G, Boulton M, Cai J, Jiang WG. Placenta growth factor is over-expressed and has prognostic value in human breast cancer. Eur J Cancer 2005;41:2819-27.
13. Jenum PA, Stray-Pedersen B, Melby KK, et al. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 1998;36:2900-6.
14. Vatten LJ, Eskild A, Nilsen TIL, Jeansson S, Jenum PA, Staff AC. Changes in circulating level of angiogenic factors from first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol 2007;196:239-41.
15. Melbye M, Wohlfahrt J, Lei U, et al. a-Fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence. J Natl Cancer Inst 2000;92:1001-5.
16. Lukanova A, Andersson R, Wulff M, et al. Human chorionic gonadotropin and α-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study. Am J Epidemiol 2008;168:1284-91.
17. Lukanova A, Toniolo P, Zeleniuch-Jacquotte A, et al. Insulin-like growth factor I in pregnancy and maternal risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006;15:2489-93.